Lumexa Imaging (LMRI) Financials: Revenue & Earnings
LMRI$11.56-0.11 -0.94%
$1.11B
Market Cap
—
P/E
—
Forward P/E
—
Score
Lumexa Imaging (LMRI) Financials: Revenue & Earnings
LMRI price $11.56 -0.11 -0.94%
- Ticker
- LMRI
- Price
- $11.56
- Change
- -0.11 -0.94%
- Market cap ?
- $1.11B
- Beta ?
- 1.01
- Sector
- Healthcare
- Industry
- Medical - Devices
Fair value
LMRI fair value $17.13. Price $11.56. Price is 33% below fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 77.72M. Growth 4.27%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 9.87% (beta 1.0). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 96.07M. Net debt 903.68M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-11 | — | 0.20 | — | 270.27M |
| 2026-08-12 | 0.20 | 0.15 | 264.16M | 263.12M |
| 2026-05-12 | 0.18 | 0.12 | 252.54M | 249.52M |
| 2026-03-26 | -0.38 | 0.05 | 267.73M | 261.17M |
| 2025-12-03 | -0.03 | 0.05 | 260.08M | 261.17M |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-06-10 | Mittl Robert Louis Jr. | Buy | 19.36K | — | — |
| 2026-06-10 | Lungren Matthew | Buy | 19.36K | — | — |
| 2026-06-10 | Karlin Bridget E | Buy | 19.36K | — | — |
| 2026-06-10 | Joseph Molly | Buy | 19.36K | — | — |
| 2026-06-10 | EISENBERG GLENN A | Buy | 19.36K | — | — |
| 2026-06-10 | Cooper Henry Lee | Buy | 19.36K | — | — |
| 2026-06-10 | BRODNAX BRETT | Buy | 19.36K | — | — |
| 2026-05-19 | BRODNAX BRETT | Buy | 35.00K | $7.25 | 253.75K |
| 2026-05-14 | Cooper Henry Lee | Buy | 30.00K | $7.44 | 223.11K |
| 2026-02-25 | Walker James Edward Jr. | Buy | 12.41K | — | — |
| 2025-12-12 | Martin James Anthony | Buy | 27.03K | — | — |
| 2025-12-12 | Martin James Anthony | Buy | 27.03K | — | — |
| 2025-12-12 | Walker James Edward Jr. | Buy | 4.93K | — | — |
| 2025-12-12 | Zulla Caitlin | Buy | 64.86K | — | — |
| 2025-12-12 | Zulla Caitlin | Buy | 64.86K | — | — |
| 2025-12-12 | BRODNAX BRETT | Buy | 27.03K | — | — |
| 2025-12-12 | Joseph Molly | Buy | 27.03K | — | — |
| 2025-12-12 | Stewart Russell | Buy | 4.23K | — | — |
| 2025-12-12 | Stewart Russell | Buy | 4.23K | — | — |
| 2025-12-12 | Szeker Julie | Buy | 81.08K | — | — |
| 2025-12-12 | Szeker Julie | Buy | 66.18K | — | — |
| 2025-12-12 | Szeker Julie | Sell | 1.25M | — | — |
| 2025-12-11 | Martin James Anthony | Other | 388.89K | $18.50 | 7.19M |
| 2025-12-11 | Walker James Edward Jr. | Other | 55.55K | $18.50 | 1.03M |
| 2025-12-11 | Mittl Robert Louis Jr. | Other | 91.26K | — | — |
| 2025-12-11 | Szeker Julie | Other | 12.62K | — | — |
| 2025-12-11 | Szeker Julie | Other | 63.89K | $18.50 | 1.18M |
| 2025-12-11 | Szeker Julie | Other | 66.18K | — | — |
| 2025-12-11 | Stewart Russell | Other | 194.44K | $18.50 | 3.60M |
| 2025-12-11 | Zulla Caitlin | Other | 833.33K | $18.50 | 15.42M |
| 2025-12-11 | Zulla Caitlin | Other | 14.95K | — | — |
| 2025-12-11 | REGAN BRIAN THOMAS | Other | 0 | — | — |
| 2025-12-11 | BRODNAX BRETT | Other | 22.22K | $18.50 | 411.11K |
| 2025-12-11 | Cooper Henry Lee | Other | 422.22K | $18.50 | 7.81M |
| 2025-12-11 | EISENBERG GLENN A | Other | 22.22K | $18.50 | 411.11K |
| 2025-12-11 | Joseph Molly | Other | 22.22K | $18.50 | 411.11K |
| 2025-12-11 | Karlin Bridget E | Other | 22.22K | $18.50 | 411.11K |
| 2025-12-11 | Lungren Matthew | Other | 22.22K | $18.50 | 411.11K |
| 2025-12-11 | Welsh, Carson, Anderson & Stowe XII Cayman, L.P. | Other | 49.01K | — | — |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 104, holders +14 vs prior quarter. Ownership 32.95%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| BROWN ADVISORY INC | 5.78M | 4.07M | +238.85% | 65.17M |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 3.45M | 1.12M | +47.94% | 38.96M |
| THINK INVESTMENTS LP | 2.56M | 2.56M | New | 28.87M |
| JUPITER TOPCO LLC | 2.15M | 2.15M | New | 24.27M |
| BLACKROCK, INC. | 1.40M | -127.57K | -8.36% | 15.77M |
| JPMORGAN CHASE & CO | 1.15M | 49.96K | +4.52% | 13.25M |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.07M | 11.84K | +1.12% | 12.07M |
| GOLDMAN SACHS GROUP INC | 807.43K | 41.92K | +5.48% | 9.11M |
| ROYCE & ASSOCIATES LP | 789.04K | 459.04K | +139.10% | 8.90M |
| SCHONFELD STRATEGIC ADVISORS LLC | 768.89K | 568.19K | +283.10% | 8.67M |
| BRIGADE CAPITAL MANAGEMENT, LP | 665.90K | 665.90K | New | 7.51M |
| RTW INVESTMENTS, LP | 650.00K | 0 | 0.00% | 7.33M |
| MILLENNIUM MANAGEMENT LLC | 627.99K | -86.69K | -12.13% | 7.08M |
| GEODE CAPITAL MANAGEMENT, LLC | 626.32K | -47.82K | -7.09% | 7.07M |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 625.27K | 206.74K | +49.40% | 7.05M |
| ARROWMARK COLORADO HOLDINGS LLC | 602.05K | -1.05M | -63.58% | 6.79M |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 600.00K | -700.00K | -53.85% | 6.77M |
| LONGAEVA PARTNERS L.P. | 528.80K | -28.62K | -5.13% | 5.96M |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | 467.34K | 467.34K | New | 5.27M |
| STATE STREET CORP | 459.13K | 82.34K | +21.85% | 5.18M |
| FRANKLIN TEMPLETON INC | 448.54K | 125.64K | +38.91% | 5.06M |
| BULLSEYE ASSET MANAGEMENT LLC | 390.19K | 370.19K | +1850.93% | 4.40M |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 357.05K | 0 | 0.00% | 4.03M |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 292.92K | -12.66K | -4.14% | 3.30M |
| POINT72 ASSET MANAGEMENT, L.P. | 280.96K | 179.69K | +177.42% | 3.17M |
Earnings and financials
Lumexa Imaging Holdings, Inc. Common Stock (LMRI) trades at $11.56, with a market cap of $1.11B and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn